Posted on: March 28, 2012 by Angela Sormani
European life sciences fundraising and investments still haven’t reached anywhere near the heady 2006 levels But news of Index Ventures most recent fundraising are sending vibes of optimism and hope for a revival of European biotech.
Tags: Abingworth Life Sciences, Advent Venture Partners, EMBL Ventures, GlaxoSmithKline, Global Life Science Ventures, Index Ventures, Johnson & Johnson, Life Sciences Partners, MVM Life Sciences Partners, New Enterprise Associates, New Science Ventures, Seroba-Kernel, Truffle Capital, TVM Capital
Posted on: January 25, 2012 by Angela Sormani
Prosensa, a Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases, has raised €23 million (US$29.8 million) in new equity financing. The financing was led by new investor New Enterprise Associates (NEA) and was supported by existing investors, Abingworth, Life Sciences Partners, Gimv, Idinvest Partners and MedSciences Capital. PRESS RELEASE Prosensa, the Dutch biopharmaceutical [...]
Tags: Abingworth, GIMV, IDinvest Partners, Life Sciences Partners, MedSciences Capital, New Enterprise Associates
Posted on: June 22, 2011 by Clancy Nolan
Helsinki-based healthcare company Mendor has closed on 8.1 million euros ($11.64 million) in Series B financing from Finnish entrepreneur and investor Risto Siilasmaa, Life Sciences Partners, Finnish Industry Investment Ltd., Finnish Mutual Pension Insurance Company Ilmarinen, private Finnish investment group Biothom and Finnvera Venture Capital. The company, formed in 2006, develops diabetes technologies and services.
Tags: Finnish Industry Investment Ltd, Finnvera Venture Capital, Life Sciences Partners
Posted on: January 26, 2011 by Clancy Nolan
Medical device company Nexstim Oy has raised 11.4 million euro ($15.6 million) for its noninvasive brain diagnostic and therapy technologies. New investor Lundbeckfond Ventures led the round, which included participation from new investor Ilmarinen Mutual Pension Insurance Company, and existing investors HealthCap, Life Sciences Partners, Sitra and Finnish Industry Investment Ltd. Founded in 2000, the Finland-based company has raised roughly 30 million euro to date.
Tags: HealthCap, Ilmarinen Mutual Pension Insurance Company, Life Sciences Partners, Lundbeckfond Ventures
Posted on: February 23, 2010 by PEHub Administrator
Seahorse Bioscience, Inc., a Billerica, Mass.-based medical instrument company, closed a $5 million round of financing. Investors in the Series D round included Commonwealth Capital Ventures, FLIR Systems Inc, Rock Maple Ventures, Life Sciences Partners, Oxford Bioscience Partners, Healthcare Ventures, New Science Ventures and HLM Venture Partners.
Tags: Commonwealth Capital Ventures, FLIR Systems Inc, HealthCare Ventures, HLM Venture Partners, Life Sciences Partners, New Science Ventures, Oxford Bioscience Partners, Rock Maple Ventures
Posted on: October 23, 2009 by PEHub Administrator
BRUSSELS (Reuters) – Belgian drugmaker Movetis is considering an initial public offering (IPO) as one of several options to raise capital needed to market its leading product, its chairman said on Friday. A stock market float by the gastrointestinal specialist, which was founded in 2006 as a spin-out from Johnson & Johnson (JNJ.N), could signal [...]
Tags: Life Sciences Partners, Movetis, Sofinnova Partners